Whole-body autoradiography and quantitative organ-level distribution study of deramciclane in rats

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 2, 1999, Pages 165-174

  Hazai, István ^a   Pátfalusi, Márta ^a   Klebovich, Imre ^b   Ürmös, Iván ^b  

^a Institute for Drug Research Budapest   (Hungary)

^b EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; DERAMCICLANE FUMARATE; SEROTONIN 2 ANTAGONIST; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG TISSUE LEVEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0344197565     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991772286     Document Type: Article

References (13)

1. Berényi. E., Blaskó, G., Fekete, M., Nógrádi, M. (1990) EGIS-3886. Drugs Future. 15: 1174-1175
2. Budai, Z., Magdányi, L., Lay-Kónya, L., Mezei, T., Grasser, K., Petõcz, L., Kosoczky, I. (1979, 1980) Basic ethers and pharmaceutical compositions containing the same. Patent No. HU 179164, US 4342762
3. Gachályi, I., Gyertyán, I., Petõcz, L., Budai, Z. (1988) Psychopharmacology of a new anxiolytic agent EGIS-3886. Pharm. Res. Commun. 20 (Suppl. 1): 115-117
4. 2 receptors. Pharm. Pharmacol. Lett. 6: 82-85
5. Gachályi, I., Schmidt, É., Gyertyán, I., Vasar, R., Lang, A., Haapalinna. Á., Fekete, M., Hietala, J., Syvälahti, E., Tuomáinen, P., Männistö, P. T. (1997) Receptor binding profile and anxiolytic-type activity of deramciclane (EGIS-3886) in animal models. Drug Dev. Res. 40: 333-348
6. Hazai, I., Ürmös, I., Klebovich, I. (1995) Application of TLC-digital autoradiography as a rapid method in a pilot study of deramciclane metabolism. J. Planar Chromatogr. 8: 92-97
7. Klebovich, I., Monostory, K., Vereczkey, L., Mák, M., Tamás, J., Bojti, E. (1995) In vitro metabolism of deramciclane by rat, dog and human liver microsomes. ISSX Proc. Vol. 8: 272
8. -1. Pharm. Pharmacol. Commun. 4: 129-136
9. Kovács, I., Maksay, G., Simonyi, M. (1989) Inhibition of high affinity synaptosomal uptake of γ-aminobutyric acid by a bicyclo heptane derivative. Arzneim. Forsch. 39: 295-297
10. Lengyel, J., Bolehovszky, A., Klebovich, I., Abermann, M., Magyar, K. (1998) Absorption of the new anxiolytic compound deramciclane in rats, dogs and rabbits. Arzneim. Forsch. 48: 455-460
11. Massart, D. L., Vandeginste, B. G. M., Deming, S. N. (1988) Chemometrics, a textbook. Elsevier, Amsterdam
12. Monostory, K., Kátay, G., Vereczkey, L., Mák, M., Tamás, J., Bojti, E., Ürmös, I., Klebovich, I. (1994) Comparative studies on in vitro metabolism of deramciclane in rat, dog and human liver microsomes. 14th European Workshop on Drug Metabolism, Paris, July 3-8, Abstr. B108, p. 307
13. Szammer, J., Simon, P., Máthé, J., Wolford, A., Káplár, Gy., Lukács, Gy., Porcs-Makkay, M., Klebovich, I., Urmös, I., Abermann, M., Bojti, E., Balogh Nemes, K. (1996) Deramciclane labelled with radioactive or stabile isotope. Hungarian patent application no. 961845 HU